Find information on thousands of medical conditions and prescription drugs.

Pulmonary hypertension

In medicine, pulmonary hypertension (PH) or pulmonary artery hypertension (PAH) is an increase in blood pressure in the pulmonary artery or lung vasculature. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Arthritis
Arthritis
Bubonic plague
Hypokalemia
Pachydermoperiostosis
Pachygyria
Pacman syndrome
Paget's disease of bone
Paget's disease of the...
Palmoplantar Keratoderma
Pancreas divisum
Pancreatic cancer
Panhypopituitarism
Panic disorder
Panniculitis
Panophobia
Panthophobia
Papilledema
Paraganglioma
Paramyotonia congenita
Paraphilia
Paraplegia
Parapsoriasis
Parasitophobia
Parkinson's disease
Parkinson's disease
Parkinsonism
Paroxysmal nocturnal...
Patau syndrome
Patent ductus arteriosus
Pathophobia
Patterson...
Pediculosis
Pelizaeus-Merzbacher disease
Pelvic inflammatory disease
Pelvic lipomatosis
Pemphigus
Pemphigus
Pemphigus
Pendred syndrome
Periarteritis nodosa
Perinatal infections
Periodontal disease
Peripartum cardiomyopathy
Peripheral neuropathy
Peritonitis
Periventricular leukomalacia
Pernicious anemia
Perniosis
Persistent sexual arousal...
Pertussis
Pes planus
Peutz-Jeghers syndrome
Peyronie disease
Pfeiffer syndrome
Pharmacophobia
Phenylketonuria
Pheochromocytoma
Photosensitive epilepsy
Pica (disorder)
Pickardt syndrome
Pili multigemini
Pilonidal cyst
Pinta
PIRA
Pityriasis lichenoides...
Pityriasis lichenoides et...
Pityriasis rubra pilaris
Placental abruption
Pleural effusion
Pleurisy
Pleuritis
Plummer-Vinson syndrome
Pneumoconiosis
Pneumocystis jiroveci...
Pneumocystosis
Pneumonia, eosinophilic
Pneumothorax
POEMS syndrome
Poland syndrome
Poliomyelitis
Polyarteritis nodosa
Polyarthritis
Polychondritis
Polycystic kidney disease
Polycystic ovarian syndrome
Polycythemia vera
Polydactyly
Polymyalgia rheumatica
Polymyositis
Polyostotic fibrous...
Pompe's disease
Popliteal pterygium syndrome
Porencephaly
Porphyria
Porphyria cutanea tarda
Portal hypertension
Portal vein thrombosis
Post Polio syndrome
Post-traumatic stress...
Postural hypotension
Potophobia
Poxviridae disease
Prader-Willi syndrome
Precocious puberty
Preeclampsia
Premature aging
Premenstrual dysphoric...
Presbycusis
Primary biliary cirrhosis
Primary ciliary dyskinesia
Primary hyperparathyroidism
Primary lateral sclerosis
Primary progressive aphasia
Primary pulmonary...
Primary sclerosing...
Prinzmetal's variant angina
Proconvertin deficiency,...
Proctitis
Progeria
Progressive external...
Progressive multifocal...
Progressive supranuclear...
Prostatitis
Protein S deficiency
Protein-energy malnutrition
Proteus syndrome
Prune belly syndrome
Pseudocholinesterase...
Pseudogout
Pseudohermaphroditism
Pseudohypoparathyroidism
Pseudomyxoma peritonei
Pseudotumor cerebri
Pseudovaginal...
Pseudoxanthoma elasticum
Psittacosis
Psoriasis
Psychogenic polydipsia
Psychophysiologic Disorders
Pterygium
Ptosis
Pubic lice
Puerperal fever
Pulmonary alveolar...
Pulmonary hypertension
Pulmonary sequestration
Pulmonary valve stenosis
Pulmonic stenosis
Pure red cell aplasia
Purpura
Purpura, Schoenlein-Henoch
Purpura, thrombotic...
Pyelonephritis
Pyoderma gangrenosum
Pyomyositis
Pyrexiophobia
Pyrophobia
Pyropoikilocytosis
Pyrosis
Pyruvate kinase deficiency
Uveitis
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Depending on the cause, it can be a severe disease with a markedly decreased exercise tolerance and right-sided heart failure. It was first identified by Dr Ernst von Romberg in 1891.

Signs and symptoms

A history usually reveals gradual onset of shortness of breath, fatigue, angina pectoris, syncope (fainting) and peripheral edema.

In order to establish the cause, the physician will generally conduct a thorough medical history and physical examination. A detailed family history is taken to determine whether the disease might be familial.

Diagnosis

Normal pulmonary arterial pressure in a person living at sea level has a mean value of 12-16mmHg. Definite pulmonary hypertension is present when mean pressures at rest exceed 25 mmHg. Although pulmonary arterial pressure can be estimated on the basis of echocardiography, pressure sampling with a Swan-Ganz catheter provides the most definite measurement.

Diagnostic tests generally involve blood tests, electrocardiography, arterial blood gas measurements, X-rays of the chest (generally followed by high-resolution CT scanning). Biopsy of the lung is usually not indicated unless the pulmonary hypertension is thought to be secondary to an underlying intrinsic lung disease. Clinical improvement is often measured in a "six-minute walking test", i.e. the distance a patient can walk in six minutes, and stability and improvements in this measurement correlate with reduced mortality.

Causes and mechanisms

Pulmonary hypertension can be primary (occurring without an obvious cause) or secondary (a result of other disease processes.)

Primary PH

Primary pulmonary hypertension (PPH) is considered a genetic disorder. Certain forms of PPH have been linked to mutations in the BMPR2 gene, which encodes a receptor for bone morphogenic proteins, as well as the 5-HT(2B) gene, which codes for a serotonin receptor. Recently, characteristic proteins of human herpesvirus 8 (also known for causing Kaposi sarcoma) were identified in vascular lesions of PPH patients. However, it is not understood what roles these genes and viral particles play in PPH. PPH has also been associated to the use of appetite suppressants (e.g. Fen-phen). While genetic susceptibility to adverse drug reactions is suspected, the cause of the disease is still largely unknown.

Read more at Wikipedia.org


[List your site here Free!]


Left main coronary artery compression by an enlarged pulmonary artery in pulmonary hypertension due to diffuse parenchymal lung disease and successful
From CHEST, 10/1/05 by Caralee E. Caplan-Shaw

INTRODUCTION: Extrinsic compression of the left main coronary artery (LMCA) by an enlarged pulmonary trunk has been reported in patients with pulmonary hypertension. We report the first case of symptomatic LMCA compression in a patient with pulmonary hypertension associated with diffuse parenchymal lung disease successfully treated with bilateral lung transplantation.

CASE PRESENTATION: A 60-year-old man was referred to our center with pulmonary hypertension resulting from diffuse parenchymal lung disease due to beryllium exposure. He reported substernal chest pain dining exercise. The pain was dull, radiated to the left arm, persisted throughout the day, and was associated with dyspnea on exertion. A resting myocardial perfusion scan with thallium-201 showed perfusion defects in the LMCA territory. Right heart catheterization revealed a right atrial pressure of 3 mm Hg, a right ventricular pressure of 76/2 mm Hg, a pulmonary artery pressure of 78/31 mm Hg, and a pulmonary artery occlusion pressure of 11 mm Hg. Coronary angiography showed a 70% smooth tapered narrowing of the LMCA without other coronary artery abnormalities (Figure 1). Computerized tomography (CT) of the chest revealed bilateral coarse fibrotic changes with traction bronchiectasis and honeycombing and a main pulmonary artery diameter of 4.7 cm. CT angiography revealed LMCA compression by the main pulmonary artery with no evidence of coronary artery atherosclerosis (Figure 2a, arrow = LMCA, P = pulmonary, artery, A = aorta). Three months later, the patient underwent successful bilateral lung transplantation. Postoperatively, the patient had no recurrence of chest pain, and-exercise stress testing with technetium99m-sestamibi revealed normal exercise performance and normal myocardial perfusion at a heart rate of 171. Follow-up CT angiography showed complete resolution of the LMCA compression (Figure 2b).

[FIGURES 1-2 OMITTED]

DISCUSSIONS: LMCA compression by an enlarged pulmonary artery may cause angina, left ventricular ischemia, and sudden death. LMCA compression has been reported in patients with idiopathic PAH, PAH associated with congenital systemic-to-pulmonary shunts, and pulmonary hypertension due to chronic thromboembolic disease (1-4). Although optimal management of this entity is unknown, successful treatment of LMCA compression has been reported after surgical correction of atrial septal defects (5), LMCA stenting (6), and pulmonary thromboendarterecomy with concurrent coronary artery bypass grafting (4). We report the first case of LMCA compression in association with pulmonary hypertension due to diffuse parenchymal lung disease with clinical, radiologic, and functional improvement after bilateral lung transplantation.

CONCLUSION: LMCA compression by an enlarged pulmonary artery may occur in pulmonary hypertension due to diffuse parenchymal lung disease and may be treated successfully with lung transplantation.

REFERENCES:

(1) Kawut SM, et al. Extrinsic compression of the left main coronary artery by the pulmonary artery in patients with long-standing pulmonary hypertension. Am J Cardiol 1999;984-6.

(2) Patrat JF, et al. Left main coronary artery compression during primary pulmonary hypertension. Chest 1997;112:842-3.

(3) Bonderman D, et al. Left main coronary artery compression by the pulmonary trunk in pulmonary hypertension. Circulation 2002;105:265.

(4) Ngaage DL, et al. Left main coronary artery compression in chronic thromboembolic pulmonary hypertension. Eur J Cardiothor Surg 2005;27:512.

(5) Fujiwara K, et al. Left main coronary trunk compression by dilated pulmonary artery in atrial septal defect. Report of three cases. J Thorac Cardiovasc Surg 1992;104(2):449-52.

(6) Rich S, et al. Stenting to reverse left ventricular ischemia due to left main coronary artery compression in primary pulmonary hypertension. Chest 2001;120:1412-5.

DISCLOSURE: Caralee Caplan-Shaw, None.

Caralee E. Caplan-Shaw MD * Steven M. Kawut MD Joshua R. Sonett MD Gregory D. Pearson MD Anna Rozenshtein MD Mark A. Apfelbaum MD Selim M. Arcasoy MD Jessie S. Wilt MD Columbia University Medical Center, New York, NY

COPYRIGHT 2005 American College of Chest Physicians
COPYRIGHT 2005 Gale Group

Return to Pulmonary hypertension
Home Contact Resources Exchange Links ebay